Covid-19 test - Import export

Enak developed Mobile test laboratory for COVID-19 tests, antibody tests, and vaccinations, among other things. The labs can initially be used to test workers for COVID-19 at companies, government agencies, and hospitals. Depending on the result, a PCR test can be carried out in the same laboratory immediately afterwards to check the test result and, if necessary, to confirm it. The trailer can then be moved daily within a radius of several hundred miles without any problems.The laboratory has all the technical and medical equipments Same-day test results are available: within minutes for the antibody test and within a few hours for the PCR test. This type of mobile testing makes it possible for the first time to test larger groups of people under the same medical and technical conditions in a single location. In addition, the mobile labs meet the logistical and technical requirements for testing several hundred people in a short period of time If the laboratory is to remain in one

The Covid-19 Antigen Rapid Test Casserre is a lateral flow immunoassay intended fort he qualitative detection Sars-Cov-2 nucleocapsid antigens in nasophartngeal swab and orosharyngeal wsab from individuals wha are suspected of COVID-19 by their healtcare provider.

The Sentebiolab Senteligo™️ SARS-CoV-2 (COVID-19) Multiplex qPCR Detection test includes a Primer-Probe set inside the Reaction Mix that contains primers and probes for human RNaseP and viral N1 and N2 regions. The internal control (primer/probe set for human RNaseP gene) is used to identify possible qPCR inhibition, confirm the integrity of the reagents, and verify the quality of RNA extraction from patient material. RNaseP primers and probes included in the kit recognize the human RNaseP gene. The primers and probes for viral N1 and N2 regions specifically identify two distinct regions on the nucleocapsid (N) gene of the SARS-CoV-2 virus. These primers and probes do not recognize the SARS-CoV virus, whose genetic structure is highly similar to SARS-CoV-2.